The risk of toxoplasmic encephalitis in HIV-infected patients with different serological profiles of antitoxoplasma antibodies

Authors

DOI:

https://doi.org/10.15587/2519-4798.2016.74318

Keywords:

HIV-infection, prevalence of toxoplasmosis, serological profile of toxoplasmatic antibodies, risk of toxoplasmatic encephalitis

Abstract

Aim of the work. To study the prevalence of serological signs of toxoplasmatic invasion among the HIV-positive population, structure and dynamics of antitoxoplasmatic antibodies and the risk of development of toxoplasmatic encephalitic.

Methods of research. 926 HIV-positive persons were under three years observation: cohort of seropositives of toxoplasmosic included 531 persons and the cohort of seronegative ones – 395. Annually there were determined anti -Toxoplasma IgM, IgG and the frequency of toxoplasmosis of encephalitis in cohorts, the absolute and relative risk, the additional part of population risk were calculated.

Results. The prevalence of seropositivity of toxoplasmosis in HIV-infected patients in Ivano-Frankivsk region is 57,25±1,6 %, that caused 86.84 % of additional part of population risk of toxoplasmatic encephalitis. The number of men (58,55 %) was more than the one of women (41,45 %). In seropositive cohort 4,16 % had toxoplasmatic encephalitis, that is 6 times more that in the cohort of seronegatives. The highest risk of morbidity was in the group of patients with seroreversion (21,43 %), that is 5 times more than in the whole cohort of seropositive persons (relative risk = 4,74) and 28 times more than in seronegative one (relative risk = 28.20). Seroreversion was also attended with the raised risk of toxoplasmatic encephalitis comparing with seronegative cohort (relative risk = 11,45).

Conclusion: the highest risk of toxoplasmatic encephalitis was in patients with seroreversion of antibodies to toxoplasmas

Author Biography

Ігор Гнатович Грижак, SHEE "Ivano-Frankivsk National Medical University" Galytska str., 2, Ivano-Frankivsk, Ukraine, 76018

Associate professor

Department of Infectious Diseases and Epidemiology

References

  1. Flegr, J., Prandota, J., Sovičková, M., Israili, Z. H. (2014). Toxoplasmosis – A Global Threat. Correlation of Latent Toxoplasmosis with Specific Disease Burden in a Set of 88 Countries. PLoS ONE, 9 (3), e90203. doi: 10.1371/journal.pone.0090203
  2. Furtado, J., Smith, J., Belfort, R., Gattey, D., Winthrop, K. (2011). Toxoplasmosis: A global threat. Journal of Global Infectious Diseases, 3 (3), 281. doi: 10.4103/0974-777x.83536
  3. Jones, J. L. (2001). Toxoplasma gondii Infection in the United States: Seroprevalence and Risk Factors. American Journal of Epidemiology, 154 (4), 357–365. doi: 10.1093/aje/154.4.357
  4. Popovich, O. O. Moroz, I. V, Chabanov, F. A. (2011). Toxoplazmoz (analiz fundamentalnikh danykh) [Toxoplasmosis (analysis of fundamental data)]. Novosty mediciny i farmacii, 5 (356). Available at: http://www.mif-ua.com/archive/article/16333
  5. Zaporozhan, V. M., Aryayev, M. L. (2004). HIV and AIDS. Kyiv: "Zdorovia", 636.
  6. VIL-infekcia v Ukraini. Buleten № 44 [HIV-infection in Ukraine. Newsletter number 44] (2015). Kyiv, 37. Available at: http://ucdc.gov.ua/uploads/documents/c21991/2b87e22809b7504610e7583b934cf583.pdf
  7. C. Hoffmann, J. K. Rockstroh (Eds.) (2012). Cerebral toxoplasmosis. HIV 2012/2013. Medizin Fokus Verland, Hamburg, 740, 345–350. Available at: http://www.hivbook.com
  8. Klinichnyi protocol diagnostyky i likuvannia oportunistychnykh infekcij i zahalnykh symptomiv u VIL-infikovanykh doroslykh ta pidlitkiv [Clinical protocol for diagnosis and treatment of opportunistic infections and general symptoms in HIV-infected adults and adolescents] (2007). MOZ Ukrayiny, 182, 45. Available at: http://ucdc.gov.ua/uploads/documents/5416f7/5e383386d320c87999c2801c80fcdcd8.pdf
  9. Klinichnyi protocol antyretrovirusnoi terapii VIL-infekcii v doroslykh ta pidlitkiv [Clinical protocol for antiretroviral treatment of HIV infection in adults and adolescents] (2010). MOZ Ukrayiny, 551, 189. Available at: http://ucdc.gov.ua/uploads/documents/17d68b/b5fdd660e1cf98ee0b35bd1e43fd482f.pdf
  10. Hryzhak, I. H. (2014). Laboratorna diahnostyka cerebralnoho toxoplasmozu [Laboratory diagnostics of cerebral toxoplasmosis]. Infekcijni khvoroby, 1, 46–50.
  11. Moskalenko, V. F., Gulchiy, O. P., Golubchikov et. al; Moskalenko, V. F. (Ed.) (2009). Biostatistics. Kyiv: Book Plus, 184.
  12. Seromonitorynh toksopolazmozu u VIL-infikovanykh zhinok [Seromonitoring Toxoplasmosis in HIV-infected women] (2009). Associated infectious and parasitic diseases. Ternopil: TSMA, 55–57.
  13. Xiao, Y., Yin, J., Jiang, N., Xiang, M., Hao, L., Lu, H. et. al. (2010). Seroepidemiology of human Toxoplasma gondii infection in China. BMC Infectious Diseases, 10 (1). doi: 10.1186/1471-2334-10-4
  14. Osunkalu, V., Sulaimon A., Onyiaorah, I., Nkolika, O. (2011). Seroprevalence of Toxoplasma gondii IgG antibody in HIV-infected patients at the Lagos University Teaching Hospital. HIV/AIDS – Research and Palliative Care, 101. doi: 10.2147/hiv.s15532
  15. Gutiérrez, M., Soriano, V., Bravo, R., Vallejo, A., Gonzalez-Lahoz, J. (1994). Seroreversion in Patients with End-Stage HIV Infection. Vox Sanguinis, 67 (2), 238–239. doi: 10.1111/j.1423-0410.1994.tb01669.x
  16. Zaaijer, H. L., Bloemer, M. H., Lelie, P. N. (1997). Temporary seronegativity in a human immunodeficiency virus type 1-infected man. Journal of Medical Virology, 51 (1), 80–82. doi: 10.1002/(sici)1096-9071(199701)51:1<80::aid-jmv12>3.3.co;2-l

Downloads

Published

2016-07-30

How to Cite

Грижак, І. Г. (2016). The risk of toxoplasmic encephalitis in HIV-infected patients with different serological profiles of antitoxoplasma antibodies. ScienceRise: Medical Science, (7 (3), 9–14. https://doi.org/10.15587/2519-4798.2016.74318

Issue

No. 7 (3) (2016)

Section

Medical Science

License

Copyright (c) 2016 Ігор Гнатович Грижак

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.